Skip to main content
Reena Thomas, MD, Neurology, Palo Alto, CA

ReenaParadaThomasMD

Neurology Palo Alto, CA

Neurooncology

Clinical Associate Professor, Stanford

Dr. Thomas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Thomas' full profile

Already have an account?

  • Office

    Stanford Cancer Center
    875 Blake Wilbur Drive, CC2221
    Palo Alto, CA 94304
    Phone+1 650-725-8630

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Neuro-Oncology, 2013 - 2014
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 2010 - 2013
  • MedStar Health/Georgetown University Hospital
    MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 2009 - 2010
  • Georgetown University School of Medicine
    Georgetown University School of MedicineClass of 2009
  • Cornell University
    Cornell UniversityBA, Biology, Neurobiology, 1998 - 2002

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2011 - 2026
  • VA State Medical License
    VA State Medical License 2009 - 2011
  • American Board of Psychiatry and Neurology Neurology

Publications & Presentations

PubMed

Lectures

  • CXCR4 blockade at the end of irradiation to improve local control of glioblastoma (GBM). 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • Reckoningwith Health’ssocial Context
    Reckoningwith Health’ssocial ContextJanuary 23rd, 2023
  • It’s Not Rocket Science — It’s Harder
    It’s Not Rocket Science — It’s HarderMay 10th, 2021
  • CIRM Invests Nearly $44 Million to Advance Regenerative Medicine Research and Manufacturing in California
    CIRM Invests Nearly $44 Million to Advance Regenerative Medicine Research and Manufacturing in CaliforniaSeptember 30th, 2023

Other Languages

  • Spanish